24,25-DIHYDRO-24,25-DIHYDROXYFUSIDIC ACID 21,25-LACTONE
UNII BN4CJ69D3S

Substance Identification & Data

This profile provides standardized clinical and technical data for 24,25-dihydro-24,25-dihydroxyfusidic Acid 21,25-lactone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BN4CJ69D3S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3104895-07-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BN4CJ69D3S
CAS Registry Number
3104895-07-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
24,25-DIHYDRO-24,25-DIHYDROXYFUSIDIC ACID 21,25-LACTONE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C31H48O7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
KKFAZFRIFSNXPG-GSNTVBARSA-N
Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
24,25-Dihydro-24,25-dihydroxyfusidic acid 21,25-lactone
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C[C@@H]1[C@H](O)CC[C@@]2(C)[C@]1(CC[C@@]3(C)[C@]2([C@H](O)C[C@]4(/C(/[C@H](C[C@]34C)OC(C)=O)=C\5/CCC(O)C(C)(C)OC5=O)[H])[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 24,25-dihydro-24,25-dihydroxyfusidic Acid 21,25-lactone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

24,25-Dihydro-24,25-dihydroxyfusidic acid 21,25-lactone
FUSIDIC ACID IMPURITY B [EP IMPURITY]

Systematic Nomenclature

29-Nordammar-17(20)-en-21-oic acid, 16-(acetyloxy)-3,11,24,25-tetrahydroxy-, ε-lactone, (3α,4α,8α,9β,11α,13α,14β,16β)-
ent-(17Z)-3β,11β-dihydroxy-17-[(6SR)-6-hydroxy-7,7-dimethyl-2-oxooxepan-3-ylidene]-4β,8,14-trimethyl-18-nor-5β,10α-androstan-16α-yl acetate